Hempel, N.-J.; Merkl, P.; Knopp, M.M.; Berthelsen, R.; Teleki, A.; Sotiriou, G.A.; Löbmann, K.
The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles. Pharmaceutics 2021, 13, 917.
https://doi.org/10.3390/pharmaceutics13060917
AMA Style
Hempel N-J, Merkl P, Knopp MM, Berthelsen R, Teleki A, Sotiriou GA, Löbmann K.
The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles. Pharmaceutics. 2021; 13(6):917.
https://doi.org/10.3390/pharmaceutics13060917
Chicago/Turabian Style
Hempel, Nele-Johanna, Padryk Merkl, Matthias Manne Knopp, Ragna Berthelsen, Alexandra Teleki, Georgios A. Sotiriou, and Korbinian Löbmann.
2021. "The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles" Pharmaceutics 13, no. 6: 917.
https://doi.org/10.3390/pharmaceutics13060917
APA Style
Hempel, N.-J., Merkl, P., Knopp, M. M., Berthelsen, R., Teleki, A., Sotiriou, G. A., & Löbmann, K.
(2021). The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles. Pharmaceutics, 13(6), 917.
https://doi.org/10.3390/pharmaceutics13060917